NCT00368173View on ClinicalTrials.gov

IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Growth Hormone Insensitivity Syndrome (GHIS)Laron Syndrome

Interventions

DRUG

rhIGF-I/rhIGFBP-3

Trial Locations (15)

Unknown

Robert Rapaport, MD, New York

Dr. Alicia Belgorosky, Buenos Aires

Dr. Christina Bazan, San Miguel de Tucumán

Dr. Bruce King, Newcastle

Dr. Durval Damiani, São Paulo

Dr. Kwok-leung NG, Hong Kong

Dr. Mohamed EL Kholy, Cairo

Professor Annette Greuters, Berlin

Tiosano Dov, Haifa

Maria Carolina Salerno, Naples

Dr. Hilde Bjorndalen, Oslo

Dr. Carlos del Aguila, Lima

Dr. Magdalena Paskova, Košice

Professor Nursen Yordam, Ankara

Dr. Cecilia Camacho-Hubner, London

All Listed Sponsors

lead

Insmed Incorporated

INDUSTRY

NCT00368173 - IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome | Biotech Hunter | Biotech Hunter